Incyte Corp. Common Stock (NASDAQ: INCY) last traded at $108.62, down 2.46% on the session. The quote above updates while this page is open; the figures below are drawn from Incyte Corp. Common Stock’s own filings and are restated only when a new one is published.
Incyte Corp. Common Stock trades on NASDAQ under the ticker INCY. Its market capitalisation is $21.70 billion.
Valuation measures for Incyte Corp. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $21.70B |
|---|---|
| Enterprise value | $19.96B |
| P/E ratio | 15.34 |
| Price / sales | 4.05 |
| Price / book | 3.86 |
| Beta | 0.44 |
Trailing-twelve-month figures tagged in Incyte Corp. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.36B |
|---|---|
| Net income (TTM) | $1.43B |
| EPS (TTM) | $7.08 |
| Gross margin | 92.47% |
| Operating margin | 30.05% |
| Return on equity | 25.46% |
| Cash | $3.46B |
Range and volume for INCY over the past 52 weeks.
| 52-week high | $132.60 |
|---|---|
| 52-week low | $83.46 |
| Volume | 2.59M |
| Average volume | 1.64M |
| Previous close | $111.36 |
Invest a chosen dollar amount in Incyte Corp. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell INCY.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.